News|Articles|November 9, 2026

Beyond Collagen: Why Beauty Formulas Need Anti-Glycation Support

Author(s)Lauren Clardy

The nearly $850 million U.S. beauty supplement market grew 17.3% in the 52 weeks ending December 28, 2025, according to SPINS.1 Collagen represents an almost $190 million U.S. market.2 For comprehensive beauty-from-within formulations, however, supporting collagen production is only part of the equation. Protecting existing collagen is equally important.

Why Collagen Alone Isn’t Enough

Collagen gives the dermis structure, strength, and elasticity. With age, collagen production declines and existing collagen undergoes structural changes, contributing to sagging, wrinkles, and reduced elasticity.

One contributor is glycation—the nonenzymatic attachment of sugars to proteins. This process forms advanced glycation end products (AGEs), which accumulate with age and can compromise collagen’s structural integrity.3

Collagen supplements support the body’s collagen production but do not directly address glycation-related damage to existing collagen. Florabella® offers a complementary approach, with research suggesting it may help reduce AGE formation.

Florabella®: A Targeted Anti-Glycation Approach

Florabella® is a proprietary sakura, or cherry blossom, extract standardized to at least 2% caffeoyl glucose and 0.05% quercetin glucoside—bioactive compounds associated with its anti-glycation properties. Long associated with beauty in Japanese culture, cherry blossoms are now being studied for their potential to support skin health from within.

Preclinical research has examined several complementary effects:

  • Reduced AGE formation: In a cell-free in vitro glycation model examining Florabella® and its major bioactives, caffeoyl glucose and quercetin glucoside, Florabella® inhibited AGE formation by 15.1% at 100 mcg/mL and 42.6% at 300 mcg/mL.4
  • Protection against cellular damage: In human fibroblasts exposed to a glycation inducer, Florabella® inhibited glycation-associated cellular damage by 62% at 10 mcg/mL and 77% at 100 mcg/mL.4
  • Collagen production and matrix formation: Florabella® increased type I collagen protein and gene expression in cultured fibroblasts without an added stressor. In a separate collagen-gel assay exposed to a glycation inducer, treated fibroblasts showed visibly greater collagen lattice formation than untreated cells.

Human Clinical Research: Promising but Preliminary

In a randomized, double-blind, placebo-controlled study, 20 women aged 35–59 took 150 mg of Florabella® daily for eight weeks. Skin AGEs decreased significantly by 6.6% from baseline in the Florabella® group, versus a nonsignificant 2.5% reduction with placebo. The between-group difference was not statistically significant.5

Women receiving Florabella® also experienced statistically significant reductions from baseline in facial pigmented spots and reddish areas. These improvements were not statistically significant compared with placebo, but suggest potential benefits for additional aspects of skin appearance.

The findings support continued investigation of Florabella® for beauty-from-within applications. They also distinguish the preclinical evidence of anti-glycation activity from the preliminary human findings, which did not establish superiority to placebo.

Building a More Complete Collagen Formula

Collagen supplies amino acids the body uses to manufacture this structural protein. Pairing it with Florabella® offers a complementary formulation strategy: nutritional support for collagen synthesis alongside an ingredient studied for anti-glycation activity.

This approach gives formulators a point of differentiation and broadens the beauty conversation to include the structural integrity of existing collagen. Florabella® has been clinically studied at 150 mg/day and offers flexibility across powders, capsules, tablets, gummies, and beverages, subject to product-specific formulation and stability requirements.

The next evolution in beauty-from-within may be less about adding more collagen and more about supporting it comprehensively.

References

  1. Dicker S, SPINS. Presented at: Natural Products Expo West; 2026; Anaheim, CA.
  2. United States Collagen Market Size & Growth to 2031. Mordor Intelligence. February 23, 2026.
  3. Chaudhuri J, Bains Y, Guha S, et al. Cell Metab. 2018;28(3):337–352. doi:10.1016/j.cmet.2018.08.014
  4. Shimoda H, Nakamura S, Morioka M, Tanaka J, Matsuda H, Yoshikawa M. Phytother Res. 2011;25(9):1328–1335. doi:10.1002/ptr.3423
  5. Matsuyama A, Kikuchi M, Shimoda H. Effect on skin condition by 8-week ingestion of standardized cherry blossom flower extract (Sakura Extract P). International Journal of Biomedical Science. 2018;14(1).

Related to this article

Denis Neville, CoreFX Ingredients
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Denis Neville, founder and CEO of CoreFX Ingredients, about the launch of CreaSHLD-IN.
Brian Appell Givaudan
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Brian Appell, product manager, Givaudan, about the launch of NovaBerin for the metabolic health market.
Elzaphan Hotam
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Elzaphan Hotam, director at TriNutra, about new clinical and preprint data on ThymoQuin.
Komal Baldwa, founder and CEO of aspurus
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Komal Baldwa, founder and CEO of aspurus about the company’s life-stage optimized dosing platform for women’s health.